Site Evaluation Presentation Summary – Your summary of what you presented, feedback received, and changes planned.

In the mid-rotation evaluation site visit, I presented a case on pyelonephritis. It was a very young female who was suffering from a complicated UTI. I think the case was interesting because the patient only complained of chills and fever, and denied all the other parts of the ROS. we had to do the work up to find out the cause of current infection. My site evaluator, Professor Melendez, also discussed the complication of pyelonephritis with me, which I found to be very helpful. Then we review my procedure logs together to ensure that I was on track with the completion of the procedures. Lastly, I got quizzed on pharm cards.

In the final evaluation site visit, I presented a case on a woman with PMHx of anemia presents with dizziness and lightheadedness.  Due to the limited lab work we had in the urgent care setting, we had to send the patient to the ED for further work up and evaluation. However, Professor Melendez and I also talked about what else we could have done for the patient and all the other possible differential that we should have ruled out. We also had a discussion on how the neuro and cardio system could have played an important role for patient presented with dizziness. After the case presentation, I also presented an article on Trichomonas treatment. I chose to present this article because it was one of the most recent study done on the effectiveness of multi-dose vs single dose therapy in patients with Trichomonas vaginitis. Lastly, my procedure logs and Typhon patient logs are reviewed by Professor Melendez. I also got quizzed on the new pharm cards.

My site evaluator did not comment much on the way I presented my H&Ps, articles, and pharm cards. However, he gave a lot of useful comments on the way that the patient should had been evaluated. This will be very beneficial and applicable to my future rotations when I am generating a list of differential and evaluation for the patients.

This entry is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license.